HONG KONG, Oct 18 (SCMP): China’s decision to join Covax was seen as a boost to the global scheme to ensure fair access to Covid-19 vaccines for poorer countries, but membership could benefit itself as well as any nations receiving its doses.
Joining the initiative, after having initially opted out, will give China access to vaccines not previously available in its domestic market and could help its scandal-plagued vaccine industry gain the international recognition it has lacked, experts said.
